These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1071 related items for PubMed ID: 29980607

  • 1. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
    Halkjær SI, Christensen AH, Lo BZS, Browne PD, Günther S, Hansen LH, Petersen AM.
    Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
    [Abstract] [Full Text] [Related]

  • 2. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
    Lahtinen P, Jalanka J, Hartikainen A, Mattila E, Hillilä M, Punkkinen J, Koskenpato J, Anttila VJ, Tillonen J, Satokari R, Arkkila P.
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
    El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T.
    Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769
    [Abstract] [Full Text] [Related]

  • 4. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ.
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
    [Abstract] [Full Text] [Related]

  • 5. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
    Johnsen PH, Hilpüsch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, Goll R.
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):17-24. PubMed ID: 29100842
    [Abstract] [Full Text] [Related]

  • 6. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T, Lied GA, Sangnes DA, El-Salhy M, Hov JR, Gilja OH, Hatlebakk JG, Hausken T.
    PLoS One; 2018 Jan; 13(11):e0194904. PubMed ID: 30427836
    [Abstract] [Full Text] [Related]

  • 7. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
    El-Salhy M, Casen C, Valeur J, Hausken T, Hatlebakk JG.
    World J Gastroenterol; 2021 May 14; 27(18):2219-2237. PubMed ID: 34025075
    [Abstract] [Full Text] [Related]

  • 8. The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study.
    Madsen AMA, Halkjær SI, Christensen AH, Günther S, Browne PD, Kallemose T, Hansen LH, Petersen AM.
    Scand J Gastroenterol; 2021 Jul 14; 56(7):761-769. PubMed ID: 34000958
    [Abstract] [Full Text] [Related]

  • 9. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
    Browne PD, Cold F, Petersen AM, Halkjær SI, Christensen AH, Günther S, Hestbjerg Hansen L.
    Gut Microbes; 2021 Jul 14; 13(1):1-16. PubMed ID: 34074214
    [Abstract] [Full Text] [Related]

  • 10. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
    Huang HL, Chen HT, Luo QL, Xu HM, He J, Li YQ, Zhou YL, Yao F, Nie YQ, Zhou YJ.
    J Dig Dis; 2019 Aug 14; 20(8):401-408. PubMed ID: 31070838
    [Abstract] [Full Text] [Related]

  • 11. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T, Hausken T, Hov JR, Valeur J, Sangnes DA, El-Salhy M, Gilja OH, Hatlebakk JG, Lied GA.
    Scand J Gastroenterol; 2019 Jun 14; 54(6):690-699. PubMed ID: 31190584
    [Abstract] [Full Text] [Related]

  • 12. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
    Körner E, Lorentz A.
    J Appl Microbiol; 2023 Mar 01; 134(3):. PubMed ID: 36882216
    [Abstract] [Full Text] [Related]

  • 13. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T, Joossens M, Vázquez-Castellanos JF, Christiaens E, Heyerick L, Boelens J, Verhasselt B, van Vlierberghe H, De Vos M, Raes J, De Looze D.
    Gastroenterology; 2021 Jan 01; 160(1):145-157.e8. PubMed ID: 32681922
    [Abstract] [Full Text] [Related]

  • 14. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    Halkjær SI, Lo B, Cold F, Højer Christensen A, Holster S, König J, Brummer RJ, Aroniadis OC, Lahtinen P, Holvoet T, Gluud LL, Petersen AM.
    World J Gastroenterol; 2023 May 28; 29(20):3185-3202. PubMed ID: 37346153
    [Abstract] [Full Text] [Related]

  • 15. Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis.
    Myneedu K, Deoker A, Schmulson MJ, Bashashati M.
    United European Gastroenterol J; 2019 Oct 28; 7(8):1033-1041. PubMed ID: 31662860
    [Abstract] [Full Text] [Related]

  • 16. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
    Ianiro G, Eusebi LH, Black CJ, Gasbarrini A, Cammarota G, Ford AC.
    Aliment Pharmacol Ther; 2019 Aug 28; 50(3):240-248. PubMed ID: 31136009
    [Abstract] [Full Text] [Related]

  • 17. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.
    Singh P, Alm EJ, Kelley JM, Cheng V, Smith M, Kassam Z, Nee J, Iturrino J, Lembo A.
    Gut Microbes; 2022 Aug 28; 14(1):2020067. PubMed ID: 35014601
    [Abstract] [Full Text] [Related]

  • 18. Allogenic Faecal Microbiota Transfer Induces Immune-Related Gene Sets in the Colon Mucosa of Patients with Irritable Bowel Syndrome.
    Holster S, Hooiveld GJ, Repsilber D, Vos WM, Brummer RJ, König J.
    Biomolecules; 2019 Oct 08; 9(10):. PubMed ID: 31597320
    [Abstract] [Full Text] [Related]

  • 19. The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial.
    Johnsen PH, Hilpüsch F, Valle PC, Goll R.
    EBioMedicine; 2020 Jan 08; 51():102562. PubMed ID: 31877418
    [Abstract] [Full Text] [Related]

  • 20. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T.
    Digestion; 2017 Jan 08; 96(1):29-38. PubMed ID: 28628918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.